Globally, the regenerative medicines market is witnessing high growth due to factors such as rise in research and development investments by pharmaceutical companies, rapid increase in organ transplantation, and increasing awareness regarding regenerative medicines. However, the budget restraints by laboratories and lack of experienced professionals are affecting growth of the market.

Download PDF Brochure @ http://www.marketsandmarkets.com/pdfdownload.asp?id=65442579

Based on products, the regenerative medicines market is segmented into cell-based products and acellular products. The cell-based products are further segmented into allogeneic and autologous-based products. The cell-based product segment is expected to account for the largest share in 2016 and is fastest-growing segment of the global regenerative medicines market. Further development of advanced technologies and availability of innovative cell therapies and biomaterials are expected to favoring the growth of cell-based products in coming years.

By therapy, the segments are cell therapy, gene therapy, immunotherapy, and tissue engineering where cell therapy is expected to dominate the market in 2016. Based on application, the regenerative medicines market is segmented into orthopedic & musculoskeletal spine, dermatology, CNS, cardiovascular, oncology, diabetes, and others where orthopedic & musculoskeletal spine is expected to dominate the market in 2016. The cardiovascular and oncology segments are poised to witness the highest growth rate in this market due to their increasing adoption in the research especially on cancer drug discovery.

By geography, the regions covered are North America, Europe, Asia-Pacific, and Rest of the World (RoW). North America is further segmented into the U.S. and Canada; Europe into Germany, France, the U.K., Italy, Spain, and Rest of Europe. North America is expected to dominate the global regenerative medicines market in 2016 because of advancement in research and development in this field along with investments and approvals of the regenerative products in the market.

In coming years, regenerative and stem cell research market are expected to offer huge growth potential to this market. Major players are developing cell-based therapies and immunotherapies will reduce the cost and efforts required in the field of regenerative medicine research such as identification of diseases pathways, and evaluation of potential new drugs.

About MarketsandMarkets

MarketsandMarkets is the largest market research firm worldwide in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to a multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.

Contact:
Mr. Rohan
MarketsandMarkets
701 Pike Street
Suite 2175, Seattle,
WA 98101, United States
Telephone No: 1-888-600-6441.
Email: [email protected]